Related Experiment Video
Updated: Nov 10, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK
Carlos Brotons1, Irene Moral1, Diana Fernández1
1EAP Sardenya-IIB Sant Pau, 08025 Barcelona, Spain.
Background:
The concept of global cardiovascular risk is not usually well understood by patients in consultation.
Methods:
This was a multicenter, prospective, randomized, open clinical trial of one-year duration to evaluate the effectiveness in reducing global cardiovascular risk with an intervention aimed at high-risk patients to improve information on the cardiovascular risk compared to the usual care. The intervention was focused on providing information about cardiovascular risk in a more understandable way, explaining the best practices to reduce cardiovascular risk, and tailoring information to the individual.
Results:
Four-hundred and sixty-four subjects participated in the study; 59.3% were men, and the mean age was 61.0 (SD 8.0) years. Significant reductions in systolic blood pressure (SBP) (-3.12 mmHg), body mass index (BMI) (-0.34 kg/m2), abdominal circumference (-1.24 cm), and REGICOR cardiovascular risk (-0.63) were observed in the intervention group. Overall, no differences in cardiovascular risk score were observed between groups at the end of follow-up.
Conclusions:
Providing an easy-to-understand assessment of the cardiovascular risk motivated high-risk patients to adopt a healthier lifestyle and improved cardiovascular risk after one year in the intervention group. Clinicians should assess a patient's baseline understanding of their CV risk using tools other than absolute risk before making treatment recommendations.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Angina IV: Management
Clinical Trials: Overview
Acute Coronary Syndrome IV: Interprofessional Care

